We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · May 12, 2022

Safety and Pharmacokinetics After Administration of the Second Dose of Intranasal Diazepam Within 4 h for Acute Treatment of Seizure Clusters

Epilepsia

 

Additional Info

Epilepsia
Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis
Epilepsia 2022 Apr 04;[EPub Ahead of Print], GD Cascino, D Tarquinio, JW Wheless, RE Hogan, MR Sperling, J Desai, B Vazquez, E Samara, SN Misra, E Carrazana, AL Rabinowicz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading